English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 45422/58598 (78%)
造訪人次 : 2534816      線上人數 : 241
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/5474


    題名: AZC-5(Aziridinoquinonylcarbon-5)對DNA烷基化作用能力的研究及其對Hep-2喉癌細胞毒殺作用的探討
    Studies on the DNA alkylation ability of AZC-5 and possible mechanism of death effect on Hep-2 cell induced by AZC-5
    作者: 蔡欣達
    Hsin-Da Tsai
    貢獻者: 醫學研究所
    關鍵詞: 相對存活率
    凋亡
    烷化
    AZC-5
    alkylation
    western blot
    Hoechst stain
    flow cytometry
    apoptosis
    cell cycle arrest
    1H NNR
    日期: 2002
    上傳時間: 2009-09-11 15:33:32 (UTC+8)
    摘要: AZC-5 ( bis-Aziridinoquinoylcarbon-5的簡稱)為bis-Aziridinoquinonyl 類的抗癌藥物。而上述藥物是由Aziridinylbenzoquino類的化合物衍生而來。在過去已經有實驗證實此類化合物可以藉由烷基化DNA ,使DNA與化合物結合,而影響DNA雙股螺旋打開,進而影響癌細胞的增殖。本論文所用藥物AZC-5即是有此特性的新合成雙體結構的化合物。由 in vitro 的實驗結果證明AZC-5在2mM~200mM濃度下的確可烷基化DNA,使DNA雙股不易分開為單股。而在細胞毒性及存活率的實驗中 , 利用MTT assay的方法測試細胞的相對存活率及Trypan blue染色計算細胞死亡率。結果發現人類喉癌細胞Hep-2隨著劑量及時間的增加會增加其死亡率 , 並且與正常細胞Skin Fibroblast有明顯差異。Hep-2細胞經AZC-5作用24 hrs.後其IC50=5.5mM。
    而在AZC-5造成Hep-2細胞死亡的機制探討上,我們發現在AZC-5作用24 hrs.後低於0.75mM時會arrest在G2/M phase而大於0.75mM至3mM時則使細胞arrest 在G2/M phase ,而當藥物作用到60 hrs.時除了有G2/M arrest外並且可以在floe cytometry儀器的觀察下看到sub-G1 峰的出現,但對於調控細胞週期的重要蛋白 cdc-2 與 cdk-2在總量表現上並沒有明顯變化。
    由Hoechst stain結果中發現AZC-5作用60 hrs.後在1.5mM有明顯的apoptotic body , 而1H NMR上所得到的結果也顯示細胞膜磷酯質CH2/CH3的比值隨AZC-5作用時間的增加也顯著的上升。由western blot的結果中看到AZC-5處理Hep-2 cell 24hrs.後, p53蛋白有略微活化增加的現象 , RNA結合物質TIAR蛋白表現量也大幅增加至3倍,抑制apoptosis產生的Bcl-2蛋白表現量也很高 , 在60 hrs.時Bcl-2表現量才下降。
    AZC-5 (bis-Aziridinoquinoylcarbon-5) is a kind of anti-cancer drug like bis-aziridinoquinonyl thiaters. It’s a new compound that developed from aziridinylbenzoquinone drug. In the previous experiments, the ability of DNA alkylation by aziridinylbenzoquinone compounds had been confirmed. It’s used to disturb DNA replication and decrease the survival rate of cancer cell. We synthesis a new bis-type anti-cancer drug AZC-5 by the different chain length and composed of linker. From the results, we confirmed the ability of DNA alkylation and the cross-link with DNA by AZC-5. In the preliminary data, it’s found that the AZC-5 induces cell death of human larynx cancer cell (Hep-2) in a dose-dependent and time-dependent manner. The IC50 of AZC-5 to Hep-2 cell is 5.5 mM by MTT assay. We also found that the AZC-5 makes a lower lethal effect on human skin fibroblast cell at same concentration of Hep-2. According to the results of flow cytometry the AZC-5 induced the Hep-2 cell S phase arrest in 0.75 mM and G2/M phase in 3 mM. The apoptotic signal progression of Hep-2 induced by AZC-5 included the increase the ratio of CH2/CH3 from cell membrane phospholipid motion in a dose- & time-dependent manner as determined by 1H NMR analysis. Besides, data from Hoechst staining also revealed that a lot of apoptotic bodies could be found at 60 hrs. after treatment by AZC-5.From Western blot results , we found the AZC-5 could induced the Hep-2 cell arrest at G2/M phase at 3 mM .
    資料類型: thesis
    顯示於類別:[醫學科學研究所] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    摘要.doc32KbMicrosoft Word231檢視/開啟
    摘要.pdf66KbAdobe PDF231檢視/開啟
    摘要.ppt100KbMicrosoft Powerpoint265檢視/開啟
    摘要.ps377KbPostscript69檢視/開啟


    在TMUIR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    著作權聲明 Copyright Notice
    • 本平台之數位內容為臺北醫學大學所收錄之機構典藏,包含體系內各式學術著作及學術產出。秉持開放取用的精神,提供使用者進行資料檢索、下載與取用,惟仍請適度、合理地於合法範圍內使用本平台之內容,以尊重著作權人之權益。商業上之利用,請先取得著作權人之授權。

      The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use. Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner.

    • 瀏覽或使用本平台,視同使用者已完全接受並瞭解聲明中所有規範、中華民國相關法規、一切國際網路規定及使用慣例,並不得為任何不法目的使用TMUIR。

      By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in the statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions. Furthermore, users must not use TMUIR for any illegal purposes.

    • 本平台盡力防止侵害著作權人之權益。若發現本平台之數位內容有侵害著作權人權益情事者,煩請權利人通知本平台維護人員([email protected]),將立即採取移除該數位著作等補救措施。

      TMUIR is made to protect the interests of copyright owners. If you believe that any material on the website infringes copyright, please contact our staff([email protected]). We will remove the work from the repository.

    Back to Top
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋